Episodic Real-Time CGM Use in Adults with Type 2 Diabetes: Results of a Pilot Randomized Controlled Trial

Real-time CGM (rtCGM) during the COVID-19 Pandemic and its Impact on Time in Range

(2021) Joost van der Linden et al.   Diabetes Technology & Therapeutics

Intensification patterns and the probability of HbA1c goal attainment in Type 2 diabetes mellitus: real-world evidence for the concept of ‘intensification inertia’

(2019) K. M. Pantalone et al.   DIABETIC MEDICINE

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting

(2019) Luigi F. Meneghini et al.   DIABETES OBESITY & METABOLISM

Glycaemic control after treatment intensification in patients with type 2 diabetes uncontrolled on two or more non‐insulin antidiabetic drugs in a real‐world setting

(2019) Silvia Canivell et al.   DIABETES OBESITY & METABOLISM

9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020

(2019)   DIABETES CARE

Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections

(2018) Roy W. Beck et al.   ANNALS OF INTERNAL MEDICINE

Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes

(2018) Urvi Desai et al.   DIABETES CARE

Clinical inertia to insulin initiation and intensification in the UK: A focused literature review

(2017) Kamlesh Khunti et al.   Primary Care Diabetes

Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings

(2017) Laura A. Young et al.   JAMA Internal Medicine

Treatment intensification for patients with type 2 diabetes and poor glycaemic control

(2016) A. Z. Fu et al.   DIABETES OBESITY & METABOLISM

Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis

(2015) Karel Kostev et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: It is time to face the evidence

(2012) U. L. Malanda et al.   DIABETES CARE

Self-Monitoring of Blood Glucose in Noninsulin-Using Type 2 Diabetic Patients: Right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users

(2012) W. H. Polonsky et al.   DIABETES CARE

Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

(2012) K. Khunti et al.   DIABETES OBESITY & METABOLISM

Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients With Type 2 Diabetes

(2011) R. A. Vigersky et al.   DIABETES CARE

Benefits of self-monitoring blood glucose in the management of new-onset Type 2 diabetes mellitus: The St Carlos Study, a prospective randomized clinic-based interventional study with parallel groups

(2010) Alejandra DURÁN et al.   Journal of Diabetes